system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Aged, Asian Continental Ancestry Group, Biomarkers, Case-Control Studies, Chi-Square Distribution, China, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Genetic Predisposition to Disease, Humans, Linear Models, Logistic Models, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Pedigree, Plasminogen Activator Inhibitor 1, Risk Factors, Smoking, Time Factors, Up-Regulation.
user
Is plasma plasminogen activator inhibitor-1 associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population? Context: To identify predictors of end-stage proliferative diabetic retinopathy (PDR) in a cohort of individuals with type 2 diabetes mellitus (T2DM) from the Northern Chinese Han population. We investigated characteristics of 153 consecutive diabetic patients with end-stage PDR (62 males, 91 females), 123 consecutive PDR patients without end-stage PDR (48 males, 75 females), and 151 normal subjects (63 males, 88 females). Only one eye of each patient or healthy subject was included in this study. Univariate logistic regression models and multivariate logistic regression models were constructed to evaluate the predictors of end-stage PDR. In univariate analysis, systolic blood pressure, diastolic blood pressure, duration of diabetes, family history of T2DM, and plasminogen activator inhibitor-1 (PAI-1) were significently associated with end-stage PDR. After multivariate analysis, family history of T2DM, plasma PAI-1 levels, smoking, and duration of diabetes were four positive predictors associated with end-stage PDR.
assistant
Higher plasma levels of PAI-1 were associated with end-stage PDR in the Northern Chinese Han population with T2DM. Final Decision: yes